Logotype for American Healthcare REIT Inc

American Healthcare REIT (AHR) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for American Healthcare REIT Inc

Q4 2024 earnings summary

17 Dec, 2025

Executive summary

  • Achieved a milestone with the first full year as a listed healthcare REIT, delivering strong financial and operational results in 2024, with a portfolio of 314 properties and occupancy rates between 87.5%–100%.

  • Reported GAAP net loss attributable to controlling interest of $(31.8) million for Q4 2024 and $(37.8) million for the full year, with net loss per diluted share of $(0.21) and $(0.29), respectively.

  • Normalized Funds from Operations (NFFO) per diluted share was $0.40 for Q4 and $1.41 for the year, reflecting strong operational performance.

  • Over $650 million invested in external growth in managed long-term care segments in 2024, with $1.36 billion raised in gross proceeds through equity offerings and ATM program.

  • Benefited from favorable long-term care fundamentals, driven by demographic tailwinds and limited new supply in senior housing.

Financial highlights

  • Total portfolio Same-Store NOI grew 21.6% year-over-year in Q4 2024 and 17.7% for the full year; consolidated cash NOI rose to $389.95M from $341.78M in FY 2023.

  • SHOP segment Same-Store NOI grew 66.6% in Q4 and 52.8% for the year; ISHC/Trilogy segment grew 28% in Q4 and 23.8% for the year.

  • Reported normalized funds from operations (NFFO) of $0.40 per diluted share in Q4 and $1.41 for full year 2024, within guidance.

  • Net Debt-to-Adjusted EBITDA improved from 8.5x at end of 2023 to 4.3x at end of 2024.

  • Adjusted EBITDA for Q4 2024 was $91.2 million.

Outlook and guidance

  • 2025 Same-Store NOI growth guidance: 7%-10% total, 10%-12% for ISHC/Trilogy, 18%-22% for SHOP, -1% to +1% for Outpatient Medical, and -1.5% to -0.5% for Triple-Net Lease.

  • NFFO per share guidance for 2025: $1.56-$1.60, reflecting double-digit growth over 2024.

  • Net income per diluted share guidance for 2025: $0.26 to $0.30.

  • Expected 2025 investments: $80M–$100M in development, $86.4M in new investments in 1H25.

  • Guidance does not include unannounced investments; expects continued double-digit growth in managed segments.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more